Psychedelics: New Frontiers in Alternative Medicine cannabissciencetech.com
6
contents
c a n n a b i s s c i e n c e a n d t e c h n o l o g y
®
| m a y / j u n e 2 0 2 2 | v o l 5 • n o s 1
8
The Path to Legalized, Accessible
Psilocybin Therapy
L A RRY BERE SFORD
What would legalization and widespread availability of psilocybin
therapy look like? Here, we connect with Dr. Sunil Aggarwal, a
palliative care physician and cofounder of the Advanced Integrative
Medical Science Institute (AIMS) in Seattle, Washington, to find out.
12
A New Clinical Trial in South Africa
Aims to Study the Effect of Psilocybin
on HIV Positive Women with Major
Depressive Disorder
ERIN MC E VOY
In this interview, Donaghue Woodman, Head of Research
and Development and Chief Medical Information Officer
at Cannsun, provides an in-depth look at their current
clinical trial on the effects of psilocybin in treating a
prevalent yet unresolved issue in South Africa.
15
Anticipating Legalization:
Making Psilocybin Accessible
DE A N H A RRIS
Here we present an outline of the areas that might
be critical in creating an infrastructure for building
the right psilocybin production space.
19
A Highly Contiguous Draft Reference
Genome for the Psilocybe Cubensis
Mushroom Is Now Available
FR A NK PRIS C A RO
A brief summary of a new peer-reviewed paper detailing
the assembly of a highly contiguous draft reference genome
for the Psilocybe cubensis mushroom by Kevin McKernan,
Medicinal Genomics Chief Science Officer, and colleagues.
21
Psilocybin Therapy for PTSD
and Depression
J A ME S S C HWA R T Z
An overview of the therapeutic role of psychedelics that
goes back thousands of years, as well as the new research
and the application of microdosing principles that have
created renewed interest in the power of psychedelics.
8
on the cover:
khamkula / adobestock.com
25
Cannabis and Psychedelics
Research: A Conversation
with Dr. Denise Vidot
MEG A N L'HEUREU X
Dr. Denise C. Vidot, an epidemiologist at
the University of Miami and Founder of the
International Cannabis & Psychedelic Research
Collaborative, shares her research background,
a short overview of her talk from this year's
Cannabis Science Conferences West titled,
"Co-Use of Cannabis and Psilocybin to Manage
Mental Health Amid the COVID-19 Pandemic:
Preliminary Results from the International
COVID-19 Cannabis Health Study," and more.
Follow us on social media for more updates
on the cannabis industry!
6b9d44
@CannSciTech
@CannabisSciTech
6b9d44
@CannabisScienceTechnology
@CannabisScienceTechnology
